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he axonal initial segment is a unique subdomain of
the neuron that maintains cellular polarization and
contributes to electrogenesis. To obtain new insights
into the mechanisms that determine protein segregation in
this subdomain, we analyzed the trafﬁcking of a reporter
protein containing the cytoplasmic II–III linker sequence
involved in sodium channel targeting and clustering (Garrido,
J.J., P. Giraud, E. Carlier, F. Fernandes, A. Moussif, M.P.
Fache, D. Debanne, and B. Dargent. 2003.
 
 Science.
 
 300:
2091–2094). Here, we show that this reporter protein is
preferentially inserted in the somatodendritic domain and
T
 
is trapped at the axonal initial segment by tethering to the
cytoskeleton, before its insertion in the axonal tips. The
nontethered population in dendrites, soma, and the distal
part of axons is subsequently eliminated by endocytosis.
We provide evidence for the involvement of two indepen-
dent determinants in the II–III linker of sodium channels.
These ﬁndings indicate that endocytotic elimination and
domain-selective tethering constitute a potential mecha-
nism of protein segregation at the axonal initial segment of
hippocampal neurons.
 
Introduction
 
The asymmetrical architecture of the neuron defines two
domains: the somatodendritic domain and the axonal domain.
The boundary between the soma and the axon comprises a
unique and highly specialized subdomain of the neuron, the
axonal initial segment (AIS). The molecular architecture of
the AIS shares some homology with the organization of the
nodes of Ranvier (Salzer, 2003). It is characterized by segre-
gation of the cytoskeletal adaptor complex ankyrin G/
 
 
 
 IV
spectrin, linked to a dense network of actin, and by a high
density of the voltage-gated sodium channels Na
 
v
 
1.2 and
Na
 
v
 
1.6 and of members of the L1 cell adhesion molecule
(CAM) family (Peles and Salzer, 2000; Boiko et al., 2003;
Salzer, 2003). The AIS constitutes a barrier that restricts the
lateral mobility of membrane proteins through differential
tethering to cytoskeletal components (Kobayashi et al.,
1992; Winckler et al., 1999) and blocks the diffusion of
phospholipids (Nakada et al., 2003). The formation of this
barrier is linked to the presence of the actin network
(Winckler et al., 1999) and correlates with the accumulation
of membrane proteins like sodium channels (Nakada et al.,
2003). The high density of sodium channels ensures generation
of the action potential, a fundamental signal in neuronal
communication (Catterall, 2000). Thus, the AIS maintains
neuronal polarization and contributes to electrogenesis.
Little is known about the biogenesis of the AIS, but infor-
mation has recently emerged indicating the pivotal role of
the cytoskeletal adaptor complex ankyrin G/
 
 
 
 IV spectrin
(Bennett and Baines, 2001; Salzer, 2003). The expression of
either ankyrin G (Zhou et al., 1998; Jenkins and Bennett,
2001) or 
 
 
 
 IV spectrin (Komada and Soriano, 2002) is man-
datory for the assembly of molecules of the L1 CAM family
and sodium channels. At the molecular level, sodium channels
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from rat brain are composed of an 
 
 
 
 subunit, the pore-
forming protein Na
 
v
 
1, and the auxiliary subunits, 
 
 
 
2 or
 
 
 
4 and 
 
 
 
1 or 
 
 
 
3 (Catterall, 2000; Isom, 2001; Salzer,
2003; Yu et al., 2003). This complex molecular organiza-
tion has hampered dissection of targeting and/or cluster-
ing motifs of sodium channels. Therefore, we developed
an approach based on CD4 chimera expression in cul-
tured hippocampal neurons to assess whether any of the
large intracellular regions of Na
 
v
 
1.2 contained sufficient
information for sorting and specific membrane organiza-
tion. Using this approach, we have recently shown that
sodium channel targeting and clustering at the AIS is
specified by a motif within the cytoplasmic loop linking
homologous domains II–III (the II–III linker) of the
Na
 
v
 
1 proteins (Garrido et al., 2003). This signal was suf-
ficient to relocalize the somatodendritic potassium chan-
nel K
 
v
 
2.1 at the AIS of hippocampal neurons (Garrido et
al., 2003). When the ankyrin binding motif of neurofas-
cin (Davis and Bennett, 1994), a member of L1 CAMs,
was replaced by the II–III linker of sodium channel
Na
 
v
 
1.2, the resulting neurofascin–sodium channel chi-
mera was concentrated at the AIS of hippocampal neurons
(Lemaillet et al., 2003). This process involves a direct associ-
ation with the ankyrin repeat domain of ankyrin G (Le-
maillet et al., 2003).
The upstream events leading to membrane protein seg-
regation within the AIS have yet to be dissected (Winckler
and Mellman, 1999). Taking into account very recent
studies on axonal sorting, several models are conceivable,
that may not be mutually exclusive. One scenario is that
an AIS protein is nonselectively inserted in the plasma
membrane of both somatodendritic and axonal domains
and subsequently eliminated in the dendrites, the soma,
and in the distal part of the axon by endocytosis where it
is tethered by ankyrin G at the AIS. Such a multistep pro-
cess would be coordinated by independent molecular
determinants, i.e., internalization and tethering motifs. It
is significant that somatodendritic endocytosis has been
shown to be involved in the axonal compartmentalization
of a CD4 chimera bearing the COOH terminus of Na
 
v
 
1.2
(Garrido et al., 2001) and more recently, of the synaptic
protein VAMP2 (Sampo et al., 2003). In each case, the
abrogation of the internalization signal impaired axonal
polarization (Garrido et al., 2001; Sampo et al., 2003). A
second possibility is that an AIS protein is selectively
sorted and inserted in the axonal domain, as observed in
the case of NgCAM, the avian homologue of L1 (Sampo
et al., 2003). After lateral diffusion, a fraction is tethered
at the AIS whereas the distal population is eliminated by
endocytosis. Alternatively, membrane proteins preassem-
bled with ankyrin G can be selectively sorted to the AIS,
as a consequence of polarized transport along microtu-
bules involving KIF5, a member of the kinesin super fam-
ily (Nakata and Hirokawa, 2003). Finally, the possibility
that segregation of a given protein at the AIS involves
both direct routing and transcytosis cannot be excluded.
For example, Sampo et al. (2003) have shown that Ng-
CAM is selectively routed to axons via a targeting motif
localized in its extracellular domain. Wisco et al. (2003)
have shown that NgCAM is preferentially inserted in the
somatodendritic domain and subsequently sorted to the
axons by transcytosis, a process mediated by an internal-
ization motif located in the cytoplasmic COOH terminus
of NgCAM.
The present study was aimed at analyzing the trafficking
of a CD4 chimera bearing the II–III linker of Na
 
v
 
1.2 (CD4-
Na
 
v
 
1.2 II–III) in hippocampal neurons, to obtain new in-
sights into the mechanisms that determine protein segrega-
tion in the AIS. At the steady-state, the surface distribution
of CD4-Na
 
v
 
1.2 II–III is restricted to the AIS of transfected
hippocampal neurons (Garrido et al., 2003). We show here
that CD4-Na
 
v
 
1.2 II–III is preferentially inserted in the so-
matodendritic domain but is subsequently eliminated by en-
docytosis, whereas it is accumulated at the AIS by a diffusion
trap due to the high concentration of ankyrin G. Ankyrin G
tethering involves a conserved glutamate residue within the
sodium channel clustering motif whereas endocytosis is gov-
erned by a segment located in the NH
 
2
 
 terminus of linker
II–III of Na
 
v
 
1.2.
 
Results
 
Involvement of a glutamate residue in sodium channel 
clustering at the AIS
 
The addition of the II–III linker of Na
 
v
 
1.2 to the human
CD4 receptor deleted of its cytoplasmic tail, resulted in a
surface distribution of the chimera (CD4-Na
 
v
 
1.2 II–III)
markedly restricted to the AIS when expressed by transfec-
tion in hippocampal neurons (Fig. 1 A, left). The AIS was
identified by the absence of the somatodendritic marker
MAP2, and by staining for ankyrin G. In addition, CD4-
Na
 
v
 
1.2 II–III was resistant to Triton X-100 extraction be-
fore cell fixation (Fig. 1 A, right), a feature reflecting
tethering to the cytoskeleton, presumably via ankyrin G
(Winckler et al., 1999). These features are governed by a
27-residue AIS motif (Garrido et al., 2003) that contains
two potential phosphorylation sites for casein kinase II
and clusters of acidic residues (Fig.1 C). To identify the
critical residue(s) in this motif we decided to evaluate the
contribution of acidic and serine residues by site-directed
mutagenesis (Fig. 1, B–E). The substitution of both
E1111 and D1113 with alanine residues drastically al-
tered the distribution of the chimera. CD4-Na
 
v
 
1.2 II–III
E1111A-D1113A was localized in both somatodendritic
and axonal domains with a loss of concentration at the
AIS. In contrast, replacing E1115, EE1120-1121, E1125,
and D1127A by alanine did not affect the steady-state dis-
tribution of the chimeras. When only E1111 was substi-
tuted by either an alanine (Fig. 1 B, left) or a glutamine
residue, chimeras were no longer concentrated at the AIS
whereas the D1113A mutation did not modify the distri-
bution of CD4-Na
 
v
 
1.2 II–III (Fig. 1 B, right). Consistent
with these observations, mutants E1111A-D1113A and
E1111A lost resistance to detergent extraction, an index
of cytoskeletal tethering (Fig. 1 E). Finally mutation of
each of the serine residues (S1112 and S1126) did not al-
ter the steady-state distribution of CD4-Na
 
v
 
1.2 II–III
(unpublished data). 
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The II–III linker of Nav1.2 is recognized by an 
endocytic pathway
 
Having demonstrated that a single mutation within the AIS
motif impaired CD4-Na
 
v
 
1.2 II–III polarization, we exam-
ined whether this motif is sufficient for segregation of the
chimera at the AIS. We replaced the COOH terminus of
CD4 by a segment of 47 amino acids encompassing the AIS
motif (CD4-Na
 
v
 
1.2 1082–1128). At the steady-state, the
cell surface distribution of CD4-Na
 
v
 
1.2 1082–1128 differed
from that of CD4-Na
 
v
 
1.2 II–III, displaying expression in
dendrites, soma, and axons but with notably brighter stain-
ing at the AIS (Fig. 2 A). Nevertheless, CD4-Na
 
v
 
1.2 1082–
1128 located at the AIS was still resistant to Triton X-100
extraction (Fig. 2 B). Thus, the AIS motif of Na
 
v
 
1.2 is nec-
essary for tethering to the cytoskeleton but is not sufficient
to restrict a CD4 chimera to the AIS. In the light of our pre-
vious study (Garrido et al., 2001) and because of the differ-
ences observed in the steady-state distribution of CD4-
Nav1.2 II–III and CD4-Na
 
v
 
1.2 1082–1128, we evaluated
the possibility that endocytosis contributes to compartmen-
talization at the AIS. We first applied an immunoendocyto-
sis assay to COS-7 cells expressing CD4-Na
 
v
 
1.2 II–III.
When the surface population of CD4-Na
 
v
 
1.2 II–III was
prelabeled with an anti-CD4 antibody at 4
 
 
 
C, followed by a
20-min incubation at 37
 
 
 
C, it was found to be located in in-
tracellular vesicles visualized by confocal microscopy (Fig. 3
A). The typical endocytic pattern was resistant to an acid-
stripping treatment (Fig. 3 A, top). In COS-7 cells express-
ing CD4-Na
 
v
 
1.2 I-II (amino acids 428–753), antibody-
labeled protein was confined at the cell surface and removed
by acid stripping treatment (Fig. 3 A, bottom). We next ap-
plied a similar endocytosis assay to transfected hippocampal
neurons. Antibody-labeled CD4-Na
 
v
 
1.2 II–III vesicles were
visualized in the soma and throughout the dendrites after 30
min of endocytosis (Fig. 3 B). The presence of internalized
CD4-Na
 
v
 
1.2 II–III in endosomes throughout the somato-
dendritic domain was further confirmed by colocalization
with EEA1, a marker of somatodendritic early endosomes
(Wilson et al., 2000; Fig. 3 B, bottom).
 
Involvement of an elimination-retention mechanism in 
CD4-Na
 
v
 
1.2 II–III segregation at the AIS
 
We next identified at the molecular level the internalization
signal in Na
 
v
 
1.2 II–III. We tested the internalization of sev-
eral mutants in COS-7 cells. The sequential truncation of
Na
 
v
 
1.2 II–III up to amino acid 1030 did not impair inter-
nalization. For each mutant, the internalized antibody-prela-
beled population located in intracellular vesicles was visual-
ized by confocal microscopy. In contrast, mutants 
 
 
 
1020,
 
 
 
1010, and 
 
 
 
993 were confined at the cell surface (Fig. 4)
Figure 1. A point mutation inhibits sodium channel clustering at the AIS. (A, left) Cell surface distribution of CD4-Nav1.2 II–III in transfected 
hippocampal neurons. CD4-Nav1.2 II–III was immunodetected with an anti-CD4 antibody (green) before permeabilization and the somatodendritic 
domain was subsequently identified by MAP2 staining (red). CD4-Nav1.2 II–III was restricted at the AIS (arrow). (A, right) CD4-Nav1.2 II–III 
was resistant to Triton X-100 extraction before cell fixation and colocalized with ankyrin G. (B) Cell surface distribution of the indicated 
CD4-Nav1.2 II–III mutants. (C) Schematic representation of mutations within the AIS motif of Nav1.2. (D) Histogram of the cell surface distribution 
of CD4-Nav1.2 II–III mutants. For each mutant, the percentage of transfected CD4-positive hippocampal neurons were classified into three 
categories: CD4 staining concentrated at the AIS (hatched), localized on axons (gray shading), and uniformly distributed at the cell surface of 
somatodendritc and axonal domains (black) taking as 100% the total population of transfected neurons. Data are means  SD from three to 
five different experiments. n denotes the total number of cells analyzed for each mutation. (E) In parallel, the resistance of mutated proteins to 
Triton X-100 extraction before cell fixation was determined. Bars, 20  m.
Figure 2. Cell surface distribution of a CD4 chimera bearing the 
clustering motif of sodium channels. (A) CD4-Nav1.2 1082–1128 
was localized at the cell surface of soma, dendrites, and axons but 
with a higher density at the AIS (arrow). (B) CD4-Nav1.2 1082–1128 
localized at the AIS was resistant to Triton X-100 extraction before 
cell fixation. Somatodendritic domains and AIS were identified by 
staining for MAP2 and ankyrin G. Bar, 20  m. 
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and were not resistant to acid-stripping treatment (un-
published data). Two internal deletions (
 
 
 
1010-1030 and
 
 
 
1002-1011) were further generated; 
 
 
 
1010-1030 mutant
impaired internalization unlike 
 
 
 
1002-1011. These data in-
dicated that 19 amino acids located in the NH
 
2
 
-terminal re-
gion of Na
 
v
 
1.2 II–III are critical for endocytosis in COS-7
cells. We next compared endocytosis of CD4-Na
 
v
 
1.2 II–III
and CD4-Na
 
v
 
1.2 II–III 
 
 
 
1010-1030 in hippocampal neu-
rons (Fig. 5 A). Differential staining of the surface and inter-
nalized populations was performed. Positive staining for the
internalized population was detected in 80% of cells express-
ing CD4-Na
 
v
 
1.2 II–III (
 
n
 
 
 
 
 
 184). This type of staining was
only detected in 18% of cells expressing 
 
 
 
1010-1030 (
 
n
 
 
 
 
 
295), indicating that the mutation impaired endocytosis. An
internalized population was observed in neurons expressing
 
 
 
1098-1111, a mutant lacking the AIS motif (Fig. 5 A).
The steady-state cell surface distribution of 
 
 
 
1010-1030 dif-
fered from that of CD4-Na
 
v
 
1.2 II–III, displaying expression
in soma, dendrites, and axons (Fig. 5 B, top). An accumula-
tion at the AIS was however clearly observed, that was resis-
tant to detergent extraction (Fig. 5 B, left bottom). The
distribution of the 
 
 
 
1010-1030 mutant was strongly remi-
niscent of CD4-Na
 
v
 
1.2 1082–1128 (Fig. 2 A). Thus, when
internalization of CD4-Na
 
v
 
1.2 II–III was impaired, its
steady-state distribution was drastically altered in spite of the
presence of a cytoskeletal tethering motif.
A comparison of the sequences of the II–III linker region
in different sodium channel types revealed that the segment
involved in endocytosis is less conserved in Na
 
v
 
1.8 and 1.9
(see Fig. S1). In view of these differences, we generated a
CD4 chimera containing the II–III linker of Na
 
v
 
1.8. In
COS-7 cells, CD4-Na
 
v
 
1.8 II–III was not endocytosed, un-
like CD4-Na
 
v
 
1.2 II–III (see Fig. S2). When expressed in
hippocampal neurons, CD4-Na
 
v
 
1.8 II–III was distributed at
the surface of the somatodendritic and axonal domains with
an accumulation at the AIS, like that observed with CD4-
Na
 
v
 
1.2 
 
 
 
1010-1030 (Fig. 5 B). It was also resistant to Tri-
ton X-100 extraction (Fig. 5 B). A histogram of the cell sur-
face distribution of the constructs is shown in Fig. 5 C. All
together, these findings strongly suggest that an elimination-
retention mechanism accounts for CD4-II–III segregation at
the AIS.
Figure 3. The cytoplasmic II–III linker of Nav1.2 is recognized 
by an endocytotic pathway. (A) COS-7 cells transfected with either 
CD4-Nav1.2 II–III or CD4-Nav1.2 I-II constructs were processed for 
an immunoendocytosis assay. After the antibody prelabeling step at 
4 C, CD4-Nav1.2 II–III and CD4-Nav1.2 I–II showed a diffuse cell 
surface staining. After 20 min of incubation at 37 C, antibody-
prelabeled CD4-Nav1.2 II–III displayed a punctate intracellular 
distribution resistant to an acidic stripping, whereas CD4-Nav1.2 I–II 
was confined to the cell surface and stripped by an acidic wash. 
(B) Endocytosis of CD4-Nav1.2 II–III in the somatodendritic domain 
of hippocampal neurons. Cells expressing CD4-Nav1.2 II–III were 
submitted to an immunoendocytosis assay for 30 min. CD4-Nav1.2 
II–III containing vesicles were distributed throughout soma and 
dendrites identified by MAP2 costaining (top) and colocalized with 
EEA1 (right enlarged view). Note the concentration of CD4-Nav1.2 
II–III at the AIS (arrow). Bars, 20  m.
Figure 4. A determinant of the linker 
II–III of Nav1.2 is involved in endocytosis 
of CD4-Nav1.2 II–III. (A) Schematic 
representation of mutations generated 
in Nav1.2 II–III. The position of the AIS 
motif is delineated between amino acid 
1102 and 1128. Internalization in COS-7 
cells is indicated (  or  ). (B) COS-7 
cells expressing the indicated mutants 
were submitted to an immunoendocytosis 
assay for 20 min at 37 C. Mutants  1030 
and  1002-1011 underwent endocytosis 
whereas  1010 and  1010-1030 were 
confined to the plasma membrane. 
Bars, 20  m.Protein compartmentalization at the axonal initial segment | Fache et al. 575
Kinetics of insertion of CD4-Nav1.2 II–III in the plasma 
membrane of hippocampal neurons
We next examined whether the insertion of newly synthe-
sized CD4-Nav1.2 II–III occurs preferentially in the somato-
dendritic domain or in the axonal domain. With this aim,
we looked at the time course of cell surface insertion of
CD4-Nav1.2 II–III in hippocampal neurons by using brefel-
din A (BFA) to block Golgi apparatus trafficking (Cid-
Arregui et al., 1995; Jareb and Banker, 1997). After a 4-h
posttransfection period, hippocampal neurons were treated
overnight with BFA, resulting in protein accumulation in
the Golgi apparatus. After removal of BFA, the cell surface
distribution of CD4-Nav1.2 II–III was visualized by immu-
nostaining at different time intervals (Fig. 6 A). At t   0,
upon BFA removal and after cell permeabilization, an intra-
cellular accumulation was observed in the perinuclear region
(unpublished data) and staining that was consistent with
BFA block. After 30 min of recovery, CD4 surface staining
was visualized on the somatodendritic membrane with an
equivalent signal at the AIS in the majority of cells (53%).
This cell population was designated somatodendritic (SD)-
AIS. A second population SD-[AIS], with brighter CD4
staining at the AIS was also observed in 24% of the cells. At
this stage of recovery, no signal was visualized on the distal
part of axons (DA; Fig. 6 A). These two cell populations
were also predominant 60 min after BFA removal but de-
creased markedly afterwards. Concomitantly, CD4-Nav1.2
II–III appeared in the distal region of axons. A surface distri-
bution in both domains with an enrichment at the AIS (SD-
[AIS]-DA) was predominant after 4 and 8 h of recovery (82
and 88%, respectively). Restriction at the AIS, as observed
in the absence of BFA treatment, began to be preponderant
24 h after removal (Fig. 6 A). In parallel, we determined the
kinetics of the insertion of CD4-Nav1.2 II–III E1111A (Fig.
6 B), a mutant that is no longer segregated at the AIS (Fig.
1). After 30 min of recovery, the E1111A mutant was visual-
ized on the somatodendritic membrane with an equivalent
signal at the AIS in 81% of cells (cell population designated
SD-AIS). At this stage of recovery, no signal was visualized
on the distal part of axons, similar to that observed with
CD4-Nav1.2 II–III (Fig. 6 A). A surface distribution in both
domains (SD-A), but with no enrichment at the AIS was
largely predominant after 2 h of recovery (77%). These ob-
servations indicated that CD4-Nav1.2 II–III is preferentially
inserted in the somatodendritic membrane and in the AIS,
where it is enriched, and subsequently in the distal part of
the axons.
Discussion
In the present study, we analyzed the trafficking of CD4-
Nav1.2 II–III, a chimera bearing the cytoplasmic region that
determines sodium channel targeting and clustering at the
AIS (Garrido et al., 2003), to explore potential mechanisms
involved in protein accumulation in this membrane subdo-
main. Evidence has been obtained for the following sce-
nario. CD4-Nav1.2 II–III is first preferentially inserted in
the plasma membrane of the soma and dendrites, and is con-
centrated at the AIS, before its insertion in axonal tips. The
high density of ankyrin G-  IV spectrin complex presum-
ably acts as a diffusion trap at the AIS. The untrapped popu-
lation in soma, dendrites, and in the distal part of axons is
subsequently eliminated by endocytosis. However, our find-
ings do not exclude the possibility that additional mecha-
nisms contribute to the accumulation of proteins at the AIS.
The time course of the appearance of CD4-Nav1.2 II–III
Figure 5. Involvement of somato-
dendritic endocytosis in the segregation 
of CD4-Nav1.2 II–III at the AIS. (A) 
 1010-1030 failed to be endocytosed 
in hippocampal neurons. After an 
immunoendocytosis assay, neurons ex-
pressing the indicated constructs were 
submitted to differential staining of the 
surface population (green) and of the 
internalized one (red). Note the absence 
of internalized  1010-1030, unlike 
CD4-Nav1.2 II–III and  1098-1111. 
(B) Cell surface distribution of  1010-
1030 and CD4-Nav1.8 II–III in hippo-
campal neurons.  1010-1030 displayed 
a cell surface distribution in MAP2-
positive domains as well as axons, with 
an enrichment at the AIS (top).  1010-
1030 was resistant to detergent extraction 
(bottom left). Cell surface distribution of 
CD4-Nav1.8 II–III (bottom middle). CD4-
Nav1.8 II–III localized at the AIS was 
resistant to Triton X-100 extraction 
(bottom right). (C) Histogram of the cell 
surface distribution of the indicated constructs. The percentage of transfected CD4-positive hippocampal neurons were classified into four 
categories: CD4 staining concentrated at the AIS ([AIS]), distributed at the cell surface of somatodendritc and axonal domains with a enrichment 
at the AIS (SD-[AIS]-DA), distributed in distal axon with no concentration at the AIS (axonal), and uniformly distributed at the cell surface 
(nonpolarized) taking as 100% the total population of transfected neurons. Data are means  SD from three to five different experiments. 
n denotes the total number of cells analyzed for each construct. Arrows indicate the AIS. Bars, 20  m.576 The Journal of Cell Biology | Volume 166, Number 4, 2004
at the cell surface revealed that the neo-synthesized protein is
preferentially inserted in the somatodendritic domain rather
than in distal regions of axons. This finding is unlikely to re-
sult from a side effect of BFA block because it has been
shown recently that the initial insertion of membrane pro-
teins in axonal tips is not perturbed by this type of treatment
(Wisco et al., 2003). We also observed that an uniform so-
matodendritic distribution preceded enrichment at the AIS.
Previous studies have indicated that the accumulation of
membrane proteins like sodium channels and neurofascin at
the AIS is coordinated by ankyrin G (Jenkins and Bennett,
2001) and is impaired by inactivation of either ankyrin G or
  IV spectrin gene expression (Zhou et al., 1998; Komada
and Soriano, 2002). When the II–III linker of Nav1.2 was
fused to a cytosolic protein like the green fluorescent pro-
tein, the resulting chimera was trapped within the AIS (Gar-
rido et al., 2003). Moreover, the AIS motif of Nav1.2 con-
tains a 9-amino acid ankyrin binding site, highly conserved
within the sodium channel Nav1 family (Lemaillet et al.,
2003). A single glutamate residue (Nav1.2 E 1111) within
this motif plays a critical role in CD4-Nav1.2 II–III tether-
ing to cytoskeleton at the AIS. Substitution of alanine or
glutamine for this residue resulted in a loss of chimera segre-
gation at the AIS, a finding underlining the functional im-
pact of removing the charge. Consistently, CD4 chimeras
bearing the II–III linkers of Nav 1.6 (Garrido et al., 2003)
and 1.8 were concentrated at the AIS and resistant to Triton
X-100 extraction. Their accumulation at the AIS was abol-
ished by mutation of the equivalent glutamate residue to ala-
nine (unpublished data). Besides, in cultured hippocampal
neurons, ankyrin B, which contains the conserved ankyrin
repeat domain that binds to sodium channels (Bennett and
Lambert, 1999; Lemaillet et al., 2003), is distributed in dis-
tal regions of axons, a localization distinct from that of
ankyrin G. However, at the steady-state, CD4-Nav1.2 II–III
was restricted at the AIS. For all these reasons, it is tempting
to propose that CD4-Nav1.2 II–III diffuses laterally in the
somatic plasma membrane and is subsequently trapped by
the cystokeleton adaptor complex ankyrin G-  IV spectrin,
at the AIS. A similar mechanism could be involved in Ng-
CAM accumulation. This axonal protein, that possesses the
highly conserved ankyrin binding site of the L1 family
(Garver et al., 1997), is initially incorporated in the somato-
dendritic domain of hippocampal neurons (Wisco et al.,
2003). This interpretation is consistent with the fact that
perturbation of the diffusion barrier formed by the AIS re-
sults in a somatic localization of NgCAM and sodium chan-
nels (Winckler et al., 1999; Nakada et al., 2003).
Despite the importance of anchoring, we show here that
cytoskeleton tethering, presumably by ankyrin G-  IV spec-
trin, is not sufficient for CD4-Nav1.2 II–III segregation at
the AIS, endocytosis is also required. The internalized popu-
lation of CD4-Nav1.2 II–III was observed throughout the
soma and dendrites and to a lesser extent, in the distal part of
axons. It was never seen within the AIS, in all observed cells.
The presence of endocytotic vesicles in these regions is consis-
tent with the steady-state distribution of CD4-Nav1.2 II–III.
The requirement for endocytosis was further demonstrated
by fact that a mutation ( 1010-1030) that abolished inter-
nalization of CD4-Nav1.2 II–III altered its steady-state distri-
Figure 6. Time course of the insertion of CD4-Nav1.2 II–III and CD4-Nav1.2 II–III E1111A in the neuronal plasma membrane. Hippocampal 
neurons were transfected with either CD4-Nav1.2 II–III or CD4-Nav1.2 II–III E1111A. After a 4-h posttransfection step, neurons were treated 
overnight either in the presence of BFA or in the absence ( BFA). The cell surface distribution of the CD4-Nav1.2 II–III and E1111A mutant 
was detected by CD4 immunostaining at different time intervals after BFA removal. (A) Time course of the insertion of CD4-Nav1.2 II–III. 
For each indicated time, CD4-Nav1.2 II–III staining was classified into four categories: SD-AIS (uniform labeling on somatodendritic and the 
AIS surface), SD-[AIS] (as in SD-AIS but with a brighter signal on the AIS), SD-[AIS]-DA (uniform labeling in somatodendritic domain and the 
distal axon with a brighter signal on the AIS), and [AIS] (staining restricted at the AIS) taking as 100% the number of CD4-positive cells. 
(B) Time course of the insertion of CD4-Nav1.2 II–III E1111A mutant. CD4 staining was classified into two categories: SD-AIS as described 
above, and SD-A (uniform labeling in somatodendritic and axonal surface with no concentration at the AIS). Data are means  SD from three 
to four experiments (the number of cells counted ranged from 200 to 800 cells for each indicated time). A representative example of each 
staining category is shown in the top part of the figure; arrows indicate the AIS and the asterisk the axon. Bars, 20  m.Protein compartmentalization at the axonal initial segment | Fache et al. 577
bution without inhibiting accumulation at the AIS. Consis-
tent with this conclusion is the observation that CD4-Nav1.8
II–III, which was not internalized either in COS-7 cells or in
hippocampal neurons, was distributed at the steady-state in
soma, dendrites, and axons, and was enriched at the AIS.
These findings also indicate that the internalization of CD4-
Nav1.2 II–III is not involved in its accumulation at the AIS
but rather in its elimination in the somatodendritic domain
and in the distal part of axons. They imply that transcytosis is
unlikely to be involved in the accumulation of CD4-Nav1.2
II–III at the AIS. However, we cannot exclude the possibility
that the presence of internalized CD4-Nav1.2 II–III in the
distal part of axons may reflect transcytosis from the somato-
dendritic domain to the axonal tips, as described for NgCAM
(Wisco et al., 2003). The sequence that governs endocytosis
of CD4-Nav1.2 II–III does not encompass a canonic inter-
nalization signal such as the di-leucine or tyrosine-based mo-
tifs (Yxx ) recognized by the clathrin-mediated endocytotic
pathway (Bonifacino and Traub, 2003). Hence, further in-
vestigation will be required to analyze the endocytotic path-
way recognized by the II–III linker of Nav1.2. A differential
regulation of endocytosis in the somatodendritic versus the
axonal domain cannot be excluded.
In conclusion, our present study shows that endocytosis
and domain-selective tethering confers CD4-Nav1.2 II–III
segregation at the AIS. However, whether the Nav1.2 so-
dium channel follows a similar trafficking pathway remains
to be explored. Multiple mechanisms probably play a role in
establishing polarized sorting to the AIS. For instance, it is
conceivable that ankyrin G-  IV spectrin may also act dur-
ing sorting, involving preassembly with sodium channels
and the CAM family. Consistent with this hypothesis is the
recent observation that when RNAi was used to eliminate
expression of Nav1.2 in cultured neurons, it resulted not
only in a loss of sodium channels but also perturbed ankyrin
G compartmentalization at the AIS (unpublished data).
Hence further investigations are required for a better under-
standing of the molecular and cellular processes involved in
the construction of the AIS.
Materials and methods
DNA constructs
CD4-Nav1.2 II–III was constructed and cloned into PCB6 as described pre-
viously (Garrido et al., 2001). Nav1.8 cDNA was a gift from John Wood
(University College London, London, UK). CD4 chimeras composed of the
II–III linker of Nav1.8 (amino acids 890–1149) were generated by sequen-
tial PCR amplification using Expand High Fidelity Taq DNA polymerase
(Roche Molecular Biochemicals). The constructs were subcloned in pCRII-
TOPO plasmid (Invitrogen) before cloning into PCB6. CD4-Nav1.2 II–III
mutants were also generated by sequential PCR amplification. Site-directed
mutants were obtained using Quick change X-L site-directed mutagenesis
kit (Stratagene). All constructs were verified by DNA sequencing.
Cell culture and transfection
Primary hippocampal neurons were prepared from embryonic day 18 rats
according to Goslin and Banker (1989) with slight modifications (Garrido
et al., 2001). Neurons were transfected after 7 to 9 d in vitro using Lipo-
fectamine 2000 (Invitrogen) (Garrido et al., 2003). COS-7 cells were cul-
tured as described previously (Garrido et al., 2001) and transfected at a
80% confluence with Lipofectamine 2000, according to the manufac-
turer’s instructions. Transfected cells were processed for immunofluores-
cence 24 h after transfection.
BFA treatment
Neurons (9 d in vitro) were transfected as described above. After 4 h,
brefeldin A (Sigma-Aldrich) was added to yield 0.75  g/ml final concentra-
tion in conditioned medium. After 14 h, coverslips were washed three
times in conditioned medium and returned to the air/CO2 incubator at
37 C. Coverslips were removed, fixed at the indicated times, and pro-
cessed for immunostaining. At t   0, before washing, 10% of the trans-
fected neurons displayed CD4 staining at the cell surface (n   1,600, four
independent experiments).
Immunofluorescence
To immunodetect the steady-state surface distribution of the chimeras in
neurons, cells were fixed in 4% paraformaldehyde for 20 min. Nonspecific
binding was blocked with 0.22% gelatin in 0.1 M phosphate buffer (PB).
Cells were incubated for 1 h with anti-CD4 antibodies (monoclonal, 1:1,000;
a gift from Jean Mérot, INSERM U533, Nantes, France); polyclonal T4-4,
1:1,500, National Institutes of Health AIDS and Reference Reagent Pro-
gram). After a permeabilization step (0.066% saponin, 0.22% gelatin in
PB), endogenous proteins were immunodetected either with anti-ankyrin
G antibodies (monoclonal, 1:30; Zymed Laboratories; polyclonal 1:60, a
gift from Gisèle Alcaraz, INSERM UMR 641, Marseille, France) or with an
anti-MAP2 monoclonal, (1:400; Sigma-Aldrich) The secondary antibodies
were goat anti–mouse or goat anti–rabbit conjugated to Alexa 563 or Al-
exa 488 (1:800; Molecular Probes). Coverslips were mounted in Mowiol.
Detergent extraction
Neurons were preincubated with anti-CD4 antibody at 16 C for 30 min,
washed, and incubated in extraction buffer (30 mM Pipes, 1 mM MgCl2, 5
mM EDTA, 0.5% Triton X-100) for 10 min at 37 C as described previously
(Garrido et al., 2003). Then, neurons were rinsed in PB, fixed, and pro-
cessed by immunofluorescence.
Immunoendocytosis assay
COS-7 cells were exposed to the primary antibody diluted in PB with
0.22% gelatin for 45 min at 4 C, extensively washed, and then transferred
to preheated DME medium and returned to the air/CO2 incubator at 37 C
for 20 min. Cells were then fixed, permeabilized, and subjected to second-
ary antibody binding. For double immunostaining, a monoclonal anti-
EEA1 antibody (1:400; Transduction Laboratories) was added to permeabi-
lized cells followed by secondary antibodies. To dissociate membrane
bound antibody before fixation, cells were incubated 10 min at 4 C in 0.2 M
acetic acid and 0.5 M NaCl.
Neurons were incubated with primary antibody in glial-conditioned
medium supplemented with 0.1% BSA for 30 min at 37 C, washed, and
fixed. After the permeabilization step, cells were processed as described
above. For differential staining of cell surface and internalized populations,
endocytosis was stopped by transferring neurons to DME-Hepes at 16 C.
Living cells were then exposed to Alexa 488–conjugated secondary anti-
body for 40 min at 16 C, washed, fixed, and further incubated 30 min with
an excess of unlabeled secondary antibody (0.2 mg/ml diluted in PB with
0.22% gelatin). After a 15-min postfixation step, neurons were permeabi-
lized and incubated with Alexa 563–conjugated secondary antibody.
Confocal microscopy
Labeling was viewed with a confocal laser scanning microscope (model
TCS; Leica). Optical sections taken in the x–y plane from consecutive z po-
sitions every 0.45–0.5  m, using the standard microscope software (Scan-
ware; Leica). Images were processed with Adobe Photoshop software.
Online supplemental material
Fig. S1 shows the alignment of the NH2-terminal region of the linker II–III
sequences of voltage-dependent sodium channels. Fig. S2 shows that the
cytoplasmic II–III linker of Nav1.8 is not recognized by an endocytotic
pathway in transfected COS-7 cells. Online supplemental material is avail-
able at http://www.jcb.org/cgi/content/full/jcb.200312155/DC1.
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